Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Remus Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
REMUS
92.02
1546.33
EPS(TTM)
Face Value(
)
Div & Yield %:
28.52
10
0
Back
Parle Industries Ltd
Parle Industries Ltd - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 Of Adjournment Of Board Meeting Scheduled To Be Held On 17Th August 2024.
Aug 17,2024
In terms of Regulation 29 of SEBI (LODR) Regulations 2015 we are pleased to inform that the meeting of the Board of Directors which was scheduled to be hedl on today i.e. 17th August 2024 adjourned on 21st August 2024 due to non-availability of quorum for the meeting.